Picture of Calcimedica logo

CALC — Calcimedica News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Graybug Vision Inc reports results for the quarter ended in September - Earnings Summary

* Graybug Vision Inc  GRAY.OQ  reported a quarterly adjusted
loss
of 46 cents​​ per share for the quarter ended in September. The
mean expectation of three analysts for the quarter was for a
loss of 44 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Graybug Vision Inc's reported EPS for the quarter was a
loss
of 46 cents​.
    * The mean earnings estimate of analysts had fallen by
about 7.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Graybug Vision Inc shares had risen by 5.3% this
quarter and
lost 45.9% so far this year.
    * The company reported a quarterly loss of $9.81 million.
    * Wall Street's median 12-month price target for Graybug
Vision
Inc is $2.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 11:29 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.44          -0.46          Missed
 Jun. 30 2022      -0.40          -0.38          Beat
 Mar. 31 2022      -0.38          -0.48          Missed
 Dec. 31 2021      -0.37          -0.41          Missed

Recent news on Calcimedica

See all news